Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series.

Background: Ocular inflammatory events following COVID-19 vaccination have been reported in the adult population.

Methods: Multinational case series of patients under the age of 18 diagnosed with ocular inflammatory events within 28 days of COVID-19 vaccination.

Results: Twenty individuals were included.

Cytokine and chemokine tear levels in patients with uveitis.

Purpose: To determine whether the levels of cytokines and chemokines in tears differ in uveitis patients and healthy subjects.

Methods: Ninety-two uveitis patients (mean age 46.4 years) and 157 control healthy subjects (mean age 49.

Distinctive clinical features of idiopathic versus infectious serpiginous choroidopathy.

Purpose: Serpiginous choroidopathy (SC) is an inflammatory disease of unknown etiology. Infectious diseases that mimic SC are termed serpiginous-like choroidopathy (SLC). The aim of this study is to determine the clinical features of infectious SLC in comparison to SC.

Corneal inflammation from pine processionary caterpillar hairs.

Purpose: Hairs from the caterpillar of the pine processionary moth, Thaumetopoea pityocampa, located in the pine forests of southern Europe and elsewhere, can become embedded in the cornea and conjunctiva. Disorders produced by the urticating hairs can be classified into a broad spectrum of severity from mild keratoconjunctivitis to anaphylactic shock. This report presents 3 cases that illustrate the range of corneal responses to embedded hairs of the processionary moth caterpillar.

Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction.

Ophthalmic bromfenac sodium sesquihydrate is a topically applied selective cyclooxygenase (COX)-2 inhibitor. It is similar to amfenac, except for a bromine atom at the C(4) of the benzoyl ring position, which markedly affects its in vitro and in vivo potency, extends the duration of anti-inflammatory activity, and enhances its inhibitory effect on COX-2 absorption across the cornea and penetration into ocular tissues. The United States Food and Drug Administration approved bromfenac in 2005 for the treatment of postoperative inflammation and the reduction of ocular pain in patients who have undergone cataract surgery.

Frosted branch angiitis diagnosed as neuro-behçet: a diagnostic and etiologic dilemma.

Purpose: To report a case of frosted branch angiitis (FBA) secondary to neuro-Behçet.

Methods: Description, diagnosis, angiogram imaging and follow-up of a 28-year-old female with FBA.

Results: 'Frosted branch angiitis' is a clinical term applied to three conditions: infiltration of vessels by malignant cells, and sheathing of vessels either secondary to an active disorder or subsequently to a previous inflammatory disease.

Surgical outcomes of uveitic glaucoma.

Purpose: Secondary glaucoma is a difficult and frequent complication of uveitis. The aim of this study is to describe the results of surgery in uveitic glaucoma and to identify situations linked to a high risk of failure of the surgery.

Methods: Retrospective observational study.